Référénces
Itis (2007–2010) standard report updated for ITIS by the Flora of North America Expertise Network, in connection with an update for USDA PLANTS
http://www.itis.gov/servlet/SingleRpt/SingleRpt?search_topic=TSN&search_value=18816
Lampert M, Andenmatten C, Schaffner W (1998) Portrait einer Arzneipflanze: Mahonia aquifolium. Zeitschrift für Phytoth 1: 117–117
Galle K, Müller-Jakic B, Proebstle A, et al. (1994) Analytical and pharmacological studies on Mahonia aquifolium. Phytomedicine 1: 59–62
Kostálová D, Kardosova A, Hajnicka V (2001) Effect of Mahonia aquifolium stem bark crude extract and one of its polysaccharide components on production of IL-8. Fitoterapia 72: 802–806
Volleková A, Kost’álová D, Kettmann V, Tóth J (2003) Antifungal activity of Mahonia aquifolium extract and its major protoberberine alkaloids. Phytother Res 17: 834–837
Wirth C, Wagner H (1997) Pharmacologically active phenolic compounds from the bark of Mahonia aquifolium. Phytomedicine 4: 357–358
Rackova L, Majekova M, Kost’alova D, Stefek M (2004) Antiradical and antioxidant activities of alkaloids isolated from Mahonia aquifolium. Structural aspects. Bioorg Med Chem 12: 4709–4715
Bezáková L, Misik V, Máleková L, et al. (1996) Lipoxygenase inhibition and antioxidant properties of bisbenzylisoqunoline alkaloids isolated from Mahonia aquifolium. Pharmazie 51: 758–761
Müller K, Ziereis K, Gawlik I (1995) The antipsoriatic Mahonia aquifolium and its active constituents; II. Antiproliferative activity against cell growth of human keratinocytes. Planta Med 61: 74–75
Seow WK, Thong YH (1993) Evaluation of the novel anti-inflammatory agent tetrandrine as a pulpotomy medicament in a canine model. Pediatr Dent 15: 260–266
Akiba S, Kato E, Sato T, Fujii T (1992) Biscoclaurine alkaloids inhibit receptor-mediated phospholipase A2 activation. Biochem Pharmacol 44: 45–50
Hashizume T, Yamaguchi H, Sato T, Fujii T (1991) Suppressive effect of biscoclaurine alkaloids on agonist-induced activation of phospholipase A2 in rabbit platelets. Biochem Pharmacol 41: 419–423
Müller K, Ziereis K (1994) The antipsoriatic Mahonia aquifolium and its active constituents; I. Pro- and antioxidant properties and inhibition of 5- lipoxygenase. Planta Med 60: 421–424
Wong CW, Thong YH, Seow WK (1993) Comparative effects of tetrandrine and berbamine on guineapig airway microvascular leakage induced by platelet-activating factor and other allergic mediators. Int J Immunopharmacol 15: 185–193
Wong CW, Seow WK, O’Callaghan JW, Thong YH (1992) Comparative effects of tetrandrine and berbamine on subcutaneous air pouch inflammation induced by interleukin-1, tumour necrosis factor and plateletactivating factor. Agents Actions 36: 112–118
Yasukawa K, Takido M, Ikekawa T, et al. (1991) Relative inhibitory activity of berberine-type alkaloids against 12-O-tetradecanoylphorbol-13-acetate- induced inflammation in mice. Chem Pharm Bull (Tokyo) 39: 1462–1465
Nakamura K, Tsuchiya S, Sugimoto Y, et al. (1992) Histamine release inhibition activity of bisbenzylisoquinoline alkaloids. Planta Med 58: 505–508
Hajnická V, Kost’álová D, Svecová D, et al. (2002) Effect of Mahonia aquifolium active compounds on interleukin-8 production in the human monocytic cell line THP-1. Planta Med 68: 266–268
Slobodníková L, Kost’álová D, Labudová D, et al. (2004) Antimicrobial activity of Mahonia aquifolium crude extract and its major isolated alkaloids. Phytother Res 18: 674–676
McCutcheon AR, Ellis SM, Hancock RE, Towers GH (1994) Antifungal screening of medicinal plants of British Columbian native peoples. J Ethnopharmacol 44: 157–169
Pepeljnjak S, Petricić J (1992) The antimicrobic effect of berberine and tinctura berberidis. Pharmazie 47: 307–308
Carpinella MC, Rai M (2009) Novel therapeutic agents from Plants. Science Publishers, Enfield, New Hampshire, pp. 60–83
Cernakova M, Kostalova D (2002) Antimicrobial activity of berberine — a constituent of Mahonia aquifolium. Folia Microbiol 47: 375–378
Wiesenauer M, Lüdtke R (1996) Mahonia aquifolium in patients with psoriasis vulgaris — an intraindividual Study. Phytomedicine 3: 231–235
Gieler U, Von der Weth A, Heger M (1995) Mahonia aquifolium: a new type of topical treatment for psoriasis. J Dermatol Treat (United Kingdom) 1:31–34
Bernstein S, Donsky H, Gulliver W, et al. (2006) Treatment of mild to moderate psoriasis with Reliéva, a Mahonia aquifolium extract — a double-blind, placebo-controlled study. Am J Ther 13: 121–126.
Lampert ML (2000) Swiss Medical Society for Phytotherapy. Mahonia aquifolium (Pursh) Nutt. as a dermatologic plant: pharmacologic and clinico-pharmacologic studies. Forsch Komplementarmed Klass Naturheilkd 7: 256–258
Nancy J, John T, Barry C, Turner OR (1983) Ethnobotany of the Nitinaht Indians of Vancouver Island. Victoria. British Columbia Provincial Museum, p. 98
Ray Verne F (1932) The Sanpoil and Nespelem: Salishan Peoples of Northeastern Washington. University of Washington Publications in Anthropology, vol. 5, p. 219
Gunther E (1973) Ethnobotany of Western Washington. Seattle. University of Washington Press. Revised edition, p. 30
Kraft K, Hobbs C, Pocket Guide to Herbal Medicine (2004) Georg Thieme Verlag, Stuttgart, New York 2004
Reuter J, Wölfle U, Weckesser S, Schempp C (2010) Which plant for which skin disease? Part 1: Atopic dermatitis, psoriasis, acne, condyloma and herpes simplex. J Dtsch Dermatol Ges 8: 788–796
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Goetz, P., Ghedira, K. Mahonia aquifolium (Pursh) Nutt. (Berberidaceae) : Mahonia. Phytothérapie 12, 189–193 (2014). https://doi.org/10.1007/s10298-014-0865-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10298-014-0865-3